Literature DB >> 29681020

Risk factors for metastasis at presentation with conventional chondrosarcoma: a population-based study.

Kehan Song1, Xiao Shi2, Xin Liang3, Hongli Wang1, Fei Zou1, Feizhou Lu1, Xiaosheng Ma1, Jianyuan Jiang4.   

Abstract

PURPOSE: The aim of the study was to investigate risk factors for metastasis at diagnosis.
METHODS: We collected patients diagnosed with conventional chondrosarcoma between 1983 and 2014 from the Surveillance, Epidemiology, and End Results (SEER) database. Each patient was classified as having metastatic or localized disease. Univariate and multivariate logistic regression analyses were applied to determine which characteristics were risk factors for metastasis at diagnosis.
RESULTS: Two thousand three hundred forty-nine patients were collected and 180 patients had metastasis at presentation. Data on age, gender, primary site, grade, and tumour size were enrolled into the multivariate logistic analysis. Greater age (60 years or older: OR = 1.872, 95% CI, 1.206 to 2.904), axial or craniofacial location (spine: OR = 1.775, 95% CI, 1.188 to 2.651; thoracic cage: OR = 2.034, 95% CI, 1.321 to 3.134; craniofacial bones: OR = 5.507, 95% CI, 3.001 to 10.107), higher grade (grade II: OR = 1.849, 95%CI, 1.181 to 2.895; grade III: OR = 4.016, 95%CI, 2.513 to 6.418), and larger tumour size (size over 10 cm: OR = 7.135, 95%CI, 2.130 to 23.893) were associated with an increased risk of metastasis at presentation.
CONCLUSIONS: Conventional chondrosarcoma patients with greater age, axial or craniofacial tumour location, higher grade, and larger tumor size were more likely to have metastasis at diagnosis.

Entities:  

Keywords:  Bone cancer; Conventional chondrosarcoma; Metastasis; Risk factor

Mesh:

Year:  2018        PMID: 29681020     DOI: 10.1007/s00264-018-3942-7

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  24 in total

1.  The biology of human chondrosarcoma. II. Variation in chemical composition among types and subtypes of benign and malignant cartilage tumors.

Authors:  H J Mankin; K P Cantley; A L Schiller; L Lippiello
Journal:  J Bone Joint Surg Am       Date:  1980-03       Impact factor: 5.284

2.  Malignant sarcoma of the pelvic bones: treatment outcomes and prognostic factors vary by histopathology.

Authors:  Muhammad Umar Jawad; Abdul Ahad Haleem; Sean P Scully
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

3.  Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database.

Authors:  Benjamin J Miller; Peter Cram; Charles F Lynch; Joseph A Buckwalter
Journal:  J Bone Joint Surg Am       Date:  2013-07-03       Impact factor: 5.284

4.  Chondrosarcoma of bone: an oncological and functional follow-up study.

Authors:  J Bruns; M Elbracht; O Niggemeyer
Journal:  Ann Oncol       Date:  2001-06       Impact factor: 32.976

5.  Osteosarcoma of the pelvis. A clinical and histopathological study of twenty-five patients.

Authors:  M Fahey; S S Spanier; R A Vander Griend
Journal:  J Bone Joint Surg Am       Date:  1992-03       Impact factor: 5.284

6.  Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.

Authors:  Brian A Schneiderman; Stephanie A Kliethermes; Lukas M Nystrom
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

7.  No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971-1990.

Authors:  Mirva Söderström; Tauno O Ekfors; Tom O Böhling; Lyly H I Teppo; Eero I Vuorio; Hannu T Aro
Journal:  Acta Orthop Scand       Date:  2003-06

8.  The diagnosis and grading of chondrosarcoma of bone: a combined cytologic and histologic approach.

Authors:  N G Sanerkin
Journal:  Cancer       Date:  1980-02       Impact factor: 6.860

Review 9.  The clinical approach towards chondrosarcoma.

Authors:  Hans Gelderblom; Pancras C W Hogendoorn; Sander D Dijkstra; Carla S van Rijswijk; Augustinus D Krol; Antonie H M Taminiau; Judith V M G Bovée
Journal:  Oncologist       Date:  2008-03

10.  Do pathological fractures influence survival and local recurrence rate in bony sarcomas?

Authors:  J A M Bramer; A A Abudu; R J Grimer; S R Carter; R M Tillman
Journal:  Eur J Cancer       Date:  2007-08-14       Impact factor: 9.162

View more
  11 in total

1.  Risk factors for distant metastasis of patients with primary triple-negative breast cancer.

Authors:  Yi Yao; Yuxin Chu; Bin Xu; Qinyong Hu; Qibin Song
Journal:  Biosci Rep       Date:  2019-06-04       Impact factor: 3.840

2.  Risk Factors for Metastasis at Initial Diagnosis With Ewing Sarcoma.

Authors:  Conglin Ye; Min Dai; Bin Zhang
Journal:  Front Oncol       Date:  2019-10-16       Impact factor: 6.244

3.  Unrecognized Chondrosarcoma as a Cause of Total Hip Arthroplasty Failure.

Authors:  Laurent Mustaki; Patrick Goetti; Nicolas Gallusser; Boris Morattel; Hannes A Rüdiger; Stéphane Cherix
Journal:  Arthroplast Today       Date:  2021-01-11

4.  Risk analysis of pulmonary metastasis of chondrosarcoma by establishing and validating a new clinical prediction model: a clinical study based on SEER database.

Authors:  Wenle Li; Shengtao Dong; Haosheng Wang; Rilige Wu; Huitao Wu; Zhi-Ri Tang; Junyan Zhang; Zhaohui Hu; Chengliang Yin
Journal:  BMC Musculoskelet Disord       Date:  2021-06-09       Impact factor: 2.362

5.  Prevalence, Risk Factors, and Prognostic Factors of Primary Malignant Bone Neoplasms with Bone Metastasis at Initial Diagnosis: A Population-Based Study.

Authors:  Zheng-Wei Xiao; Hui-Ling Guo; Hong-Chao Chen; Lai-Peng Yan; Yi-Lin Liao; Shu-Lin Li; Li-Lan Zhao; Ling-Bo Su; Jun-Jie Li; Fa-Qiang Tang
Journal:  J Oncol       Date:  2022-03-26       Impact factor: 4.375

6.  Establishment and validation of an individualized nomogram to predict distant metastasis in chondrosarcoma patients: a population-based study.

Authors:  Tien-Manh Hoang; Minh-Tien Nguyen; Weisin Chen; Chenyang Zhuang; Zixiang Wang; Hanquan Wang; Juan Li; Hong Lin
Journal:  Transl Cancer Res       Date:  2022-02       Impact factor: 1.241

7.  Prognostic Factors for Survival in Patients with Clear Cell Sarcoma: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.

Authors:  A-Bing Li; Bing-Jie Jiang; He-Hui Wang; Yu-Sheng Yang; Xiao-Bo Zhang; Guan-Hua Lan; Wu-Bin Shu
Journal:  Med Sci Monit       Date:  2019-09-15

8.  Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.

Authors:  Runzhi Huang; Zhao Sun; Huimin Zheng; Penghui Yan; Peng Hu; Huabin Yin; Jie Zhang; Tong Meng; Zongqaing Huang
Journal:  Orthop Surg       Date:  2019-10       Impact factor: 2.071

9.  Risk Factors for Incidence and Prognosis in Chondrosarcoma Patients with Pulmonary Metastasis at Initial Diagnosis.

Authors:  Minh Tien Nguyen; Yun-Qi Jiang; Xi-Lei Li; Jian Dong
Journal:  Med Sci Monit       Date:  2019-12-30

10.  Primary tumor resection benefited the survival of patients with distant metastatic gastric cancer.

Authors:  Yan Gao; Yuxin Chu; Qinyong Hu; Qibin Song
Journal:  J Res Med Sci       Date:  2021-03-31       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.